Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	SUMO ligase activity	RGPD4 RANBP2 ZNF451 RGPD3	1.35e-05	20	150	4	GO:0061665
GeneOntologyMolecularFunction	SUMO transferase activity	RGPD4 RANBP2 ZNF451 RGPD3	1.49e-04	36	150	4	GO:0019789
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD4 RANBP2 RGPD3	1.98e-05	8	150	3	GO:1990723
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD4 RANBP2 RGPD3	4.19e-05	10	150	3	GO:0044614
GeneOntologyCellularComponent	nuclear envelope	RGPD4 NEMP1 RANBP2 DPY19L1 RTEL1 PARP8 HTATIP2 ZNF354C HOXA7 NDEL1 CLIC1 RGPD3 NUP93 SORL1	5.31e-05	560	150	14	GO:0005635
GeneOntologyCellularComponent	annulate lamellae	RGPD4 RANBP2 RGPD3	1.24e-04	14	150	3	GO:0005642
GeneOntologyCellularComponent	nuclear membrane	RGPD4 NEMP1 RANBP2 DPY19L1 RTEL1 ZNF354C HOXA7 CLIC1 RGPD3 NUP93	2.19e-04	349	150	10	GO:0031965
GeneOntologyCellularComponent	nuclear pore nuclear basket	RGPD4 RANBP2 RGPD3	2.73e-04	18	150	3	GO:0044615
GeneOntologyCellularComponent	nuclear inclusion body	RGPD4 RANBP2 RGPD3	3.77e-04	20	150	3	GO:0042405
GeneOntologyCellularComponent	SUMO ligase complex	RGPD4 RANBP2 RGPD3	4.38e-04	21	150	3	GO:0106068
GeneOntologyCellularComponent	axonemal central apparatus	SPAG6 HYDIN	7.53e-04	6	150	2	GO:1990716
Domain	Ran_BP1	RGPD4 RANBP2 RGPD3	9.38e-05	12	144	3	PF00638
Domain	RANBD1	RGPD4 RANBP2 RGPD3	9.38e-05	12	144	3	PS50196
Domain	RanBD	RGPD4 RANBP2 RGPD3	1.21e-04	13	144	3	SM00160
Domain	Ran_bind_dom	RGPD4 RANBP2 RGPD3	1.21e-04	13	144	3	IPR000156
Domain	-	CACNA2D1 VWF CACHD1 VIT MDN1	2.67e-04	74	144	5	3.40.50.410
Domain	VWFA	CACNA2D1 VWF CACHD1 VIT MDN1	4.30e-04	82	144	5	PS50234
Domain	VWA	CACNA2D1 VWF CACHD1 VIT MDN1	4.81e-04	84	144	5	SM00327
Domain	VWA_N	CACNA2D1 CACHD1	5.81e-04	5	144	2	IPR013608
Domain	VWA_N	CACNA2D1 CACHD1	5.81e-04	5	144	2	PF08399
Domain	Sortilin_C	SORCS2 SORL1	5.81e-04	5	144	2	PF15901
Domain	Sortilin-Vps10	SORCS2 SORL1	5.81e-04	5	144	2	PF15902
Domain	VPS10	SORCS2 SORL1	5.81e-04	5	144	2	IPR006581
Domain	Sortilin_N	SORCS2 SORL1	5.81e-04	5	144	2	IPR031778
Domain	Sortilin_C	SORCS2 SORL1	5.81e-04	5	144	2	IPR031777
Domain	VPS10	SORCS2 SORL1	5.81e-04	5	144	2	SM00602
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	9037092
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	38838144
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	38657106
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	21205196
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	25187515
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	8603673
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	26632511
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	24403063
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	23818861
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	23536549
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	22821000
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RGPD4 RANBP2 RGPD3	2.72e-06	7	150	3	20682751
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD4 RANBP2 RGPD3	4.33e-06	8	150	3	21670213
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RGPD4 RANBP2 RGPD3	4.33e-06	8	150	3	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RGPD4 RANBP2 RGPD3	4.33e-06	8	150	3	21310149
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RGPD4 RANBP2 RGPD3	4.33e-06	8	150	3	22262462
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD4 RANBP2 RGPD3	4.33e-06	8	150	3	28745977
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	DHX36 NEMP1 CACNA2D1 FAT4 FRAS1 DPY19L1 HTATIP2 CD109 TMED7 CACHD1 ITGAV USP19 P2RX5 CLIC1 ATM PLSCR1 DNASE2 SORL1	4.65e-06	1201	150	18	35696571
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RGPD4 RANBP2 RGPD3	6.48e-06	9	150	3	18394993
Pubmed	Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.	RGPD4 RANBP2 RGPD3	6.48e-06	9	150	3	28100513
Pubmed	Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.	RGPD4 RANBP2 RGPD3	6.48e-06	9	150	3	17887960
Pubmed	The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.	RGPD4 RANBP2 RGPD3	6.48e-06	9	150	3	11553612
Pubmed	The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.	RGPD4 RANBP2 RGPD3	6.48e-06	9	150	3	10601307
Pubmed	The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.	RGPD4 RANBP2 RGPD3	6.48e-06	9	150	3	9733766
Pubmed	Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.	RGPD4 RANBP2 RGPD3	6.48e-06	9	150	3	28877029
Pubmed	The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.	RGPD4 RANBP2 RGPD3	9.23e-06	10	150	3	27160050
Pubmed	Parkin ubiquitinates and promotes the degradation of RanBP2.	RGPD4 RANBP2 RGPD3	9.23e-06	10	150	3	16332688
Pubmed	Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.	RGPD4 RANBP2 RGPD3	9.23e-06	10	150	3	8857542
Pubmed	Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.	RGPD4 RANBP2 RGPD3	9.23e-06	10	150	3	21859863
Pubmed	RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.	RGPD4 RANBP2 RGPD3	1.26e-05	11	150	3	17069463
Pubmed	An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.	RGPD4 RANBP2 RGPD3	1.26e-05	11	150	3	35771867
Pubmed	T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.	RGPD4 RANBP2 RGPD3	1.26e-05	11	150	3	34110283
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	CACNA2D1 FAT4 PABPC1L2A CRTAC1 VPS36 XPNPEP1 ITGAV SLC12A1 CLIC1 PABPC1L PDCD10 PLSCR1 DNASE2 KNG1 ALPL UEVLD	1.67e-05	1070	150	16	23533145
Pubmed	Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.	RYR1 ALPL	1.85e-05	2	150	2	30236258
Pubmed	The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.	CYP4Z1 CYP4Z2P	1.85e-05	2	150	2	28236635
Pubmed	DAAM1 and PREP are involved in human spermatogenesis.	PREP DAAM1	1.85e-05	2	150	2	31972124
Pubmed	Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.	CYP4Z1 CYP4Z2P	1.85e-05	2	150	2	15059886
Pubmed	The multi-site docking protein Gab1 is constitutively phosphorylated independent from its recruitment to the plasma membrane in Jak2-V617F-positive cells and mediates proliferation of human erythroleukaemia cells.	JAK2 GAB1	1.85e-05	2	150	2	28365441
Pubmed	Loss of Jak2 impairs endothelial function by attenuating Raf-1/MEK1/Sp-1 signaling along with altered eNOS activities.	NDOR1 JAK2	1.85e-05	2	150	2	23747947
Pubmed	Preliminary Investigation on the Involvement of Cytoskeleton-Related Proteins, DAAM1 and PREP, in Human Testicular Disorders.	PREP DAAM1	1.85e-05	2	150	2	34360857
Pubmed	Generation and characterization of mice with null mutation of the chloride intracellular channel 1 gene.	CLIC1 ALPL	1.85e-05	2	150	2	20049953
Pubmed	Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.	BRCA2 ATM	1.85e-05	2	150	2	37126020
Pubmed	The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.	CYP4Z1 CYP4Z2P	1.85e-05	2	150	2	25701119
Pubmed	Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer.	BRCA2 ATM	1.85e-05	2	150	2	27692705
Pubmed	Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.	RYR1 ALPL	1.85e-05	2	150	2	17122579
Pubmed	Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage.	RYR1 ALPL	1.85e-05	2	150	2	22131268
Pubmed	Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer.	BRCA2 ATM	1.85e-05	2	150	2	34533610
Pubmed	Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.	JAK2 GAB1	1.85e-05	2	150	2	19665053
Pubmed	Correlations of fascin-1 and cadherin-17 protein expression with clinicopathologic features and prognosis of patients with gastric cancer.	FSCN1 CDH17	1.85e-05	2	150	2	26743780
Pubmed	Epigenetic regulation of adipogenesis by PHF2 histone demethylase.	NDOR1 PHF2	1.85e-05	2	150	2	23274892
Pubmed	Low genetic heterogeneity of copy number variations (CNVs) in the genes encoding the human deoxyribonucleases 1-like 3 and II potentially relevant to autoimmunity.	DNASE1L3 DNASE2	1.85e-05	2	150	2	31022206
Pubmed	Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein.	NUAK1 ATM	1.85e-05	2	150	2	12409306
Pubmed	Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.	RGPD4 RANBP2 RGPD3	2.18e-05	13	150	3	31427429
Pubmed	Peering through the pore: nuclear pore complex structure, assembly, and function.	RGPD4 RANBP2 RGPD3 NUP93	2.19e-05	38	150	4	12791264
Pubmed	Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.	RGPD4 RANBP2 RGPD3	3.44e-05	15	150	3	14697343
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	CACNA2D1 VWF ARMC3 VPS36 ITGAV RYR1 SLC12A1 CLIC1 GSTCD PDCD10 PLSCR1 KNG1 ALPL UEVLD SORL1	3.60e-05	1016	150	15	19056867
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TTLL5 NBEA FRMD4A SORCS2 ZNF292	3.88e-05	87	150	5	12465718
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PITHD1 VWF TTLL5 TRPS1 CRTAC1 NBEA CACHD1 ARMCX4 CRMP1 NUFIP1 ADAMTS9 HECTD2 ZNF451 ATM ALPL LGI1 ZNF292	4.24e-05	1285	150	17	35914814
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	RANBP2 KIF23 ING3 RTEL1 MDN1 BRCA2 ZNF451	5.34e-05	222	150	7	37071664
Pubmed	BRCA2 is required for neurogenesis and suppression of medulloblastoma.	BRCA2 ATM	5.53e-05	3	150	2	17476307
Pubmed	Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.	BRCA2 ATM	5.53e-05	3	150	2	15084244
Pubmed	Daam1 regulates fascin for actin assembly in mouse oocyte meiosis.	DAAM1 FSCN1	5.53e-05	3	150	2	28682694
Pubmed	Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.	BRCA2 ATM	5.53e-05	3	150	2	32875559
Pubmed	BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.	BRCA2 ATM	5.53e-05	3	150	2	33414135
Pubmed	Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.	BRCA2 ATM	5.53e-05	3	150	2	17333338
Pubmed	Microtubule-bundling protein Spef1 enables mammalian ciliary central apparatus formation.	SPAG6 HYDIN	5.53e-05	3	150	2	30535028
Pubmed	SORLA/SORL1 functionally interacts with SPAK to control renal activation of Na(+)-K(+)-Cl(-) cotransporter 2.	SLC12A1 SORL1	5.53e-05	3	150	2	20385770
Pubmed	Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia.	BRCA2 ATM	5.53e-05	3	150	2	16574953
Pubmed	Is olaparib cost effective in metastatic castration-resistant prostate cancer patients with at least one favorable gene mutation in BRCA1, BRCA2 or ATM?	BRCA2 ATM	5.53e-05	3	150	2	34517749
Pubmed	Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor.	VWF ITGAV	5.53e-05	3	150	2	7505120
Pubmed	Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.	BRCA2 ATM	5.53e-05	3	150	2	29915322
Pubmed	DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities.	BRCA2 ATM	5.53e-05	3	150	2	27317574
Pubmed	Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress.	VWF ITGAV	5.53e-05	3	150	2	18927433
Pubmed	Functional Single Nucleotide Polymorphisms (SNPs) in the Genes Encoding the Human Deoxyribonuclease (DNase) Family Potentially Relevant to Autoimmunity.	DNASE1L3 DNASE2	5.53e-05	3	150	2	27116004
Pubmed	ATM-mediated DNA damage signals mediate immune escape through integrin-αvβ3-dependent mechanisms.	ITGAV ATM	5.53e-05	3	150	2	22094875
Pubmed	Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.	CYP4Z1 CYP4Z2P	5.53e-05	3	150	2	30832689
Pubmed	Tissue expression patterns identify mouse cilia genes.	ARMC3 ODAD4 SPAG6 MINDY4 HYDIN	6.22e-05	96	150	5	17971504
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	ARMC3 CRTAC1 XPNPEP1 CFAP43 SPAG6 CCDC7 FRMD4A HECTD2 LGI1	8.49e-05	415	150	9	16385451
Pubmed	Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population.	BRCA2 ATM	1.10e-04	4	150	2	20513533
Pubmed	Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.	BRCA2 ATM	1.10e-04	4	150	2	17428320
Pubmed	A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.	BRCA2 ATM	1.10e-04	4	150	2	27941124
Pubmed	TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche.	NDOR1 JAK2	1.10e-04	4	150	2	35439167
Pubmed	In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms.	NDOR1 JAK2	1.10e-04	4	150	2	38457657
Pubmed	Elevated HMGN4 expression potentiates thyroid tumorigenesis.	BRCA2 ATM	1.10e-04	4	150	2	28186538
Pubmed	The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells.	VWF ITGAV	1.10e-04	4	150	2	33576766
Pubmed	MERIT40 cooperates with BRCA2 to resolve DNA interstrand cross-links.	NDOR1 BRCA2	1.10e-04	4	150	2	26338419
Pubmed	The Ca2+ channel alpha2delta-1 subunit determines Ca2+ current kinetics in skeletal muscle but not targeting of alpha1S or excitation-contraction coupling.	CACNA2D1 RYR1	1.10e-04	4	150	2	15536090
Pubmed	D-Aspartate Depletion Perturbs Steroidogenesis and Spermatogenesis in Mice.	PREP DAAM1	1.10e-04	4	150	2	37189369
Pubmed	Hip geometry variation is associated with bone mineralization pathway gene variants: The Framingham Study.	HOXA7 ALPL	1.10e-04	4	150	2	19888898
Pubmed	Clustering of Genetic Anomalies of Cilia Outer Dynein Arm and Central Apparatus in Patients with Transposition of the Great Arteries.	ODAD4 HYDIN	1.10e-04	4	150	2	36140829
Pubmed	Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography.	PREP KNG1	1.10e-04	4	150	2	12173
Pubmed	Gene-gene interactions in breast cancer susceptibility.	BRCA2 ATM	1.10e-04	4	150	2	22072393
Pubmed	Terminal differentiation of cortical neurons rapidly remodels RanGAP-mediated nuclear transport system.	RGPD4 RANBP2 RGPD3	1.14e-04	22	150	3	27717094
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RGPD4 CACNA2D1 ZWILCH RANBP2 KIF23 TRPS1 HAUS3 NUFIP1 NDEL1 ZNF451 RGPD3 ATM NUP93 FSCN1 PDCD10	1.50e-04	1155	150	15	20360068
GeneFamily	Adhesion G protein-coupled receptors, subfamily G	ADGRG4 ADGRG6	6.12e-04	7	99	2	917
Coexpression	YAGI_AML_WITH_11Q23_REARRANGED	VIPR2 RANBP2 DPY19L1 ITGAV SPAG6 GH2 PHF2 GTF2E2 PREP ATM FSCN1	4.94e-06	346	149	11	M17123
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF23 VWF RGS5 CD109 TFDP3 ADGRG6 CDCA2 NUAK1 BRCA2 ADAMTS9 SLCO2A1	7.11e-11	196	150	11	eb8c9a4a5eb21d43ff7b25deae5896c236f669b9
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF23 VWF RGS5 CD109 ADGRG6 CDCA2 NUAK1 BRCA2 ADAMTS9 SLCO2A1	1.42e-09	197	150	10	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DAAM1 DNASE1L3	2.62e-08	199	150	9	68412bc39639edc4045437d62548f7101b9f1989
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / Treatment groups by lineage, cell group, cell type	VWF CRTAC1 ADGRG6 JAK2 NUAK1 ADAMTS9 SLCO2A1 DAAM1 FSCN1	2.73e-08	200	150	9	b036f5e22c95a3b14391785b6e91aa183b9bc9a8
ToppCell	Endothelial-A-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	VWF GH2 HOXA7 NUAK1 ADAMTS9 SLCO2A1 FSCN1 DNASE1L3	2.07e-07	183	150	8	2c3f2c25c38f0598b4787d2ec335efe00fdc9751
ToppCell	Control-Endothelial_cells-Pulmonary_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	VWF CD109 ADGRG6 HOXA7 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	2.07e-07	183	150	8	46be9f96755c7b65aeac061d95d15abeb6466034
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT4 VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	2.44e-07	187	150	8	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	VWF RGS5 CD109 CACHD1 ADGRG6 NUAK1 ADAMTS9 SLCO2A1	2.54e-07	188	150	8	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FAT4 VWF CD109 CACHD1 ADGRG6 NUAK1 ADAMTS9 SLCO2A1	2.75e-07	190	150	8	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ELOVL2 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	2.75e-07	190	150	8	ac2eb1e51459d187095152e0cd41ae54c1025c6f
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)\|343B / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ELOVL2 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	2.75e-07	190	150	8	6010f16378f2d9cde37c7e7db6a7d9666edaddcc
ToppCell	356C-Endothelial_cells-Endothelial-A_(Artery)\|356C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ELOVL2 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 FSCN1	3.22e-07	194	150	8	2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2
ToppCell	356C-Endothelial_cells-Endothelial-A_(Artery)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ELOVL2 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 FSCN1	3.22e-07	194	150	8	b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200
ToppCell	ASK454-Endothelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	FAT4 VWF RGS5 FAM171B NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.48e-07	196	150	8	14dd6956ef420b660be0baf52a66960e57d75d16
ToppCell	ASK454-Endothelial-Endothelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	FAT4 VWF RGS5 STC1 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.48e-07	196	150	8	2b777a2026b56839112fd179f2db482c49f4594a
ToppCell	distal-Endothelial-Vein-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VWF RGS5 CD109 CACHD1 ADGRG6 NUAK1 SLCO2A1 DAAM1	3.62e-07	197	150	8	3d71c93da4b88ebbd58e68ed3dbf610d4bcfc4f5
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.62e-07	197	150	8	8437c33e2c4a10a1b95343431e48d5e820b1f742
ToppCell	368C-Endothelial_cells-Endothelial-A_(Artery)\|368C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 STC1 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.62e-07	197	150	8	7caa2c86dc4d50b57a7db8f7278d1588282ad6db
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.62e-07	197	150	8	0542badae77d2f606c13cfaf361319495c354351
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.62e-07	197	150	8	b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576
ToppCell	368C-Endothelial_cells-Endothelial-A_(Artery)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 STC1 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.62e-07	197	150	8	951f18f326967206adbbfc422cce9eea3d2e0854
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.62e-07	197	150	8	a6a64581699cfcb9607b288976fa3b09648725b7
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.76e-07	198	150	8	3ae1e2b4ca77b94eaa24a8c990780aff47dface6
ToppCell	distal-1-Endothelial-Vein\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VWF RGS5 CD109 ADGRG6 NUAK1 SLCO2A1 DAAM1 DNASE1L3	3.76e-07	198	150	8	eee6cb4fe0e1caf460869d5a0a57c9d259573f10
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.76e-07	198	150	8	fb70a649e4e2edb32967328c1085dc5999c29a33
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.76e-07	198	150	8	71ee440b1ac566db63d0b415c50a0ad064d14f15
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.91e-07	199	150	8	53b6a661d381b1ed3ea96e61e8bd1750de7d9fda
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.91e-07	199	150	8	9c753043024871b1f1436fc39defac4da85e10cd
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.91e-07	199	150	8	d017dd91f9b10038f1f83753a766e534da2dbe89
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Vein\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	VWF CRTAC1 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DAAM1 FSCN1	3.91e-07	199	150	8	cfb624c7728046fc7f3ef071f57e4d7b013f3fef
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.91e-07	199	150	8	15db14eff63d5edeced0738542d5fb739225511b
ToppCell	Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.06e-07	200	150	8	98f6a86fbbe5305c71dae91e7278de9813827935
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Macrophages\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.06e-07	200	150	8	d7b89a721988660d8010c804916f5d0ef2520ee2
ToppCell	Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.06e-07	200	150	8	1ed1c673184f0c6aae04f90edbb1383b1c1f64d9
ToppCell	Lung_Parenchyma-Control-Myeloid-Macrophage\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.06e-07	200	150	8	2a1ba87ca4adf351ef8fa2b3154b86a5407b8f2f
ToppCell	distal-2-Endothelial-Vein\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DAAM1 DNASE1L3	4.06e-07	200	150	8	2785225956d2422acab90e99b7debe3709cf3308
ToppCell	Endothelial-A-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	FAT4 VWF RGS5 ELOVL2 HOXA7 NUAK1 SLCO2A1	1.96e-06	172	150	7	a3201773a25832e92dd113fad165f1ecd37f5e91
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VIPR2 TRPS1 CCDC168 DNAH14 PREP ANO3 GAB1	2.12e-06	174	150	7	ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZWILCH KIF23 HAUS3 SSTR2 ADGRG6 CDCA2 HOXA7	2.20e-06	175	150	7	3e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF RGS5 STC1 FRMD4A SLCO2A1 KCNJ15 FSCN1	2.65e-06	180	150	7	efc4c5a4dea456527526bbfd88cf70d803893671
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT4 VWF RGS5 ADGRG6 NUAK1 SLCO2A1 DNASE1L3	2.65e-06	180	150	7	27e8bbee388e64dd79d70b160b76d45b1f398006
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF CRTAC1 ADGRG6 STC1 ADAMTS9 SLCO2A1 PLSCR1	2.96e-06	183	150	7	a644258ba90acc62d571623e429d72ffc4b69203
ToppCell	Ciliated_cells-A-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	ARMC3 ODAD4 CFAP43 SPAG6 EFHC2 ASXL3 HYDIN	3.18e-06	185	150	7	d77ca57b02125a3a57a37f4aed20c89803b7d551
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	VWF CACHD1 ELOVL2 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.18e-06	185	150	7	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ARMC3 CFAP43 ADGRG6 ABCG1 ADAMTS9 HYDIN ALPK2	3.29e-06	186	150	7	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 USP43 CFAP43 DNAH14 ADAMTS9 KCNJ15 HYDIN	3.29e-06	186	150	7	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	Ciliated_cells-B-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ARMC3 ODAD4 CFAP43 SPAG6 C1orf141 EFHC2 HYDIN	3.41e-06	187	150	7	2b4262c2e7c7830a976be168cee6eeb738d4feda
ToppCell	367C-Endothelial_cells-Endothelial-D\|367C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 STC1 ADAMTS9 SLCO2A1 DNASE1L3	3.41e-06	187	150	7	1342bc614bc4045263c2eb0a535a1dd6c64e7abe
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ARMC3 ODAD4 CFAP43 SPAG6 C1orf141 EFHC2 HYDIN	3.41e-06	187	150	7	88f785932e67c613db0dda84496de351359ed962
ToppCell	367C-Endothelial_cells-Endothelial-D-\|367C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 STC1 ADAMTS9 SLCO2A1 DNASE1L3	3.41e-06	187	150	7	7aa206262b14b9f2aaa99e59da38b96c3594d2c9
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ARMC3 ODAD4 CFAP43 SPAG6 C1orf141 EFHC2 HYDIN	3.41e-06	187	150	7	8896a00b30d11b90ca42726d4e122174a30b161b
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	FRAS1 EXPH5 PARP8 CACHD1 FRMD4A SLCO2A1 HYDIN	3.54e-06	188	150	7	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Endothelial-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	VWF RGS5 ELOVL2 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	3.66e-06	189	150	7	04b565855f58ca0f343904d04be657b66e109076
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	VWF ADGRG6 STC1 ADAMTS9 SLCO2A1 PLSCR1 DNASE1L3	3.66e-06	189	150	7	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	Control-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	VWF RGS5 CACHD1 ADGRG6 NUAK1 ADAMTS9 SLCO2A1	3.79e-06	190	150	7	4e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	VWF CD109 CACHD1 ADGRG6 STC1 ADAMTS9 SLCO2A1	3.79e-06	190	150	7	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Vein\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF CRTAC1 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 FSCN1	4.06e-06	192	150	7	717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.20e-06	193	150	7	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	tumor_Lung-Endothelial_cells-Stalk-like_ECs\|tumor_Lung / Location, Cell class and cell subclass	VWF RGS5 ADGRG6 STC1 ADAMTS9 SLCO2A1 DNASE1L3	4.20e-06	193	150	7	21fec35587ffb5c0157e54a821ce3ffd3e24e536
ToppCell	Endothelial-endothelial_cell_of_vein\|World / Lineage, Cell type, age group and donor	VWF RGS5 CD109 ADGRG6 NUAK1 ADAMTS9 SLCO2A1	4.35e-06	194	150	7	3cbd9622a68e89add90e589867d88c83c5a33476
ToppCell	IPF-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 ALPL	4.35e-06	194	150	7	e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VWF CD109 STC1 ABCG1 NUAK1 ADAMTS9 SLCO2A1	4.50e-06	195	150	7	fde8e7b38b3631109b95ef111c5f6e3f9878cfbd
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF RGS5 CD109 ADGRG6 NUAK1 SLCO2A1 GSTCD	4.50e-06	195	150	7	81a98ebb0d43f416f9a8bba580531dc0cfea8f74
ToppCell	(6)_Endothelial-D\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.50e-06	195	150	7	c0005a5f2dc63a0cc254c45ac89a2f42df6f8bde
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3\|Hippocampus / BrainAtlas - Mouse McCarroll V32	EXPH5 CD109 VIT HOXA7 ADAMTS9 SLCO2A1	4.61e-06	127	150	6	9bc55cb9f4bddb274930784d12a83b9dceb35cb7
ToppCell	343B-Endothelial_cells-Endothelial-D\|343B / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.65e-06	196	150	7	99953fe0a40e242f6945150345fc0a08ed95f8f9
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.65e-06	196	150	7	d5d3028fcbfa251a206d17ec33b3b313968f9d79
ToppCell	343B-Endothelial_cells-Endothelial-D-\|343B / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.65e-06	196	150	7	5edffdc4c1ff35d9ee0e5c1bed0dc0c90b76ea00
ToppCell	tumor_Lung-Endothelial_cells\|tumor_Lung / Location, Cell class and cell subclass	VWF RGS5 STC1 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.81e-06	197	150	7	6870b311c54a73723768276a58456620f5217d43
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF ELOVL2 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.97e-06	198	150	7	68ee0baa2f5cf239f2356cc59fee9041a7732bba
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	VWF RGS5 CD109 ADGRG6 ADAMTS9 SLCO2A1 DNASE1L3	4.97e-06	198	150	7	6fd984da5d2c419aeb34c8cbd8a00440e2f820a5
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.97e-06	198	150	7	f83956c4b13b5d0a0c6e3d9f580dbf99649ef175
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VWF CD109 ABCG1 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.97e-06	198	150	7	5c82dad416938d5c460069796d808170e7dbc8d9
ToppCell	Endoth-Vasc\|World / shred by cell class for parenchyma	VWF RGS5 ABCG1 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.97e-06	198	150	7	067101d070cfaf84c7d16c6e517f8946690ad502
ToppCell	(6)_Endothelial-A_(Artery)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.97e-06	198	150	7	44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e
ToppCell	ASK428-Endothelial\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	FAT4 VWF FAM171B NUAK1 ADAMTS9 SLCO2A1 FSCN1	4.97e-06	198	150	7	d69d0ff115298596173a4278897a65007a71f5df
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)\|390C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	4.97e-06	198	150	7	5b5ccce5de82ea041465e656147cec3b8beb865b
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VWF RGS5 CD109 ADGRG6 NUAK1 SLCO2A1 DNASE1L3	5.14e-06	199	150	7	3a4deea6e11a0555d27497b7c9983350797aac69
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EXPH5 CACHD1 FCHO2 DNAH14 KCNJ15 GAB1 ALPL	5.14e-06	199	150	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	367C-Endothelial_cells\|367C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	5.14e-06	199	150	7	636ff80938907f137e955388797072ab45289062
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 FHOD3 CACHD1 NUAK1 ASXL3 KCNJ15 SORCS2	5.14e-06	199	150	7	94a7867e800df352731796de8c24cba133c29622
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VWF CD109 ABCG1 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	5.14e-06	199	150	7	e2d5c5cab102e67b0131b02392d81adaedc15965
ToppCell	367C-Endothelial_cells-Endothelial-A_(Artery)\|367C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	5.14e-06	199	150	7	29ed081bd5204a32068b420f2244f3704891547b
ToppCell	367C-Endothelial_cells-Endothelial-A_(Artery)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	5.14e-06	199	150	7	c2d85f80037f209a4a329790f475d9f98f590262
ToppCell	Neuronal-Excitatory-eC(RORB)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	VIPR2 DPY19L1 CCDC168 SPAG6 NUAK1 ANO3 GAB1	5.31e-06	200	150	7	8c803a0ce25e140b46036f6aabefc5502601f408
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ARMC3 ODAD4 CFAP43 SPAG6 C1orf141 EFHC2 HYDIN	5.31e-06	200	150	7	52aef65f01b06cd98056f17977efe525aee6eb6f
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Vein\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	VWF CRTAC1 ADGRG6 NUAK1 SLCO2A1 DAAM1 FSCN1	5.31e-06	200	150	7	7eb366b2c5394af7c77650bde6261e7dac67154e
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	5.31e-06	200	150	7	84e145619a500530f42ed0fe72468ae95f4cbf1e
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ARMC3 ODAD4 CFAP43 SPAG6 C1orf141 EFHC2 HYDIN	5.31e-06	200	150	7	55c148238d5c80c1faa3428a917ae8075be2c145
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	5.31e-06	200	150	7	cb00760ae75c30b1cb8526534aabd4ffc7c21000
ToppCell	Tracheal-10x3prime_v2-Endothelial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	VWF RGS5 CD109 ADAMTS9 SLCO2A1 FSCN1 DNASE1L3	5.31e-06	200	150	7	2e51195810bca8a98488a8a06c538feaa27f1f28
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3 ALPL	5.31e-06	200	150	7	50b8788494b744e0f0ec8c4d67a1c90ae09dca65
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Vein\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	VWF CRTAC1 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 FSCN1	5.31e-06	200	150	7	b3f93b71589251197cde96b7bc6d065c106f61cd
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ARMC3 ODAD4 CFAP43 SPAG6 C1orf141 EFHC2 HYDIN	5.31e-06	200	150	7	5abd6d81e1cc354484ae693fcd708d78926e75b5
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	VWF RGS5 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3 ALPL	5.31e-06	200	150	7	f5f24273bee3259a4a3be99ba53b88defa1286c0
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	5.31e-06	200	150	7	27507c4b41d45c7cc50e4993169c0302be22ee34
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ARMC3 ODAD4 CFAP43 SPAG6 C1orf141 EFHC2 HYDIN	5.31e-06	200	150	7	9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e
ToppCell	Biopsy_Control_(H.)-Endothelial\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	VWF RGS5 CD109 ADGRG6 NUAK1 SLCO2A1 FSCN1	5.31e-06	200	150	7	6a9b6a4b4f204598290ae21c87ddb42ac95dfc4c
ToppCell	distal-Endothelial-Vein-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	5.31e-06	200	150	7	ff88d28162e0231d5dac0e0c6bec98fa8da58a23
ToppCell	medial-Endothelial-Vein-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VWF RGS5 ADGRG6 NUAK1 ADAMTS9 SLCO2A1 DNASE1L3	5.31e-06	200	150	7	3f689029f5bc7db0af50a405f1e252aeec529077
Disease	essential thrombocythemia (is_implicated_in)	VWF JAK2	3.45e-04	6	143	2	DOID:2224 (is_implicated_in)
Disease	familial combined hyperlipidemia (is_marker_for)	VWF ALPL	3.45e-04	6	143	2	DOID:13809 (is_marker_for)
Disease	peripheral arterial disease, traffic air pollution measurement	TRPS1 NBEA VIT ADGRG6 CCDC7 FRMD4A	3.79e-04	194	143	6	EFO_0004265, EFO_0007908
Disease	disease of cellular proliferation (implicated_via_orthology)	JAK2 ATM	4.82e-04	7	143	2	DOID:14566 (implicated_via_orthology)
Disease	10-undecenoate 11:1n1 measurement	CYP4Z1 CYP4Z2P	4.82e-04	7	143	2	EFO_0021099
Disease	infertility (implicated_via_orthology)	BRCA2 ATM	4.82e-04	7	143	2	DOID:5223 (implicated_via_orthology)
Disease	factor VIII measurement, venous thromboembolism	VWF FCHO2 KNG1	5.97e-04	34	143	3	EFO_0004286, EFO_0004630
Disease	female breast cancer (is_implicated_in)	RTEL1 ATM	6.41e-04	8	143	2	DOID:0050671 (is_implicated_in)
Disease	tetradecanedioate measurement	CYP4Z2P LGI1	8.21e-04	9	143	2	EFO_0021057
Disease	corpus callosum volume measurement	CACNA2D1 C16orf95 FAM171B NUAK1	1.45e-03	100	143	4	EFO_0010299
Disease	Myeloproliferative disease	ATG2B JAK2	1.49e-03	12	143	2	C0027022
Disease	congenital left-sided heart lesions	FRAS1 C16orf95 CFAP43	1.64e-03	48	143	3	EFO_0005938
Disease	beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement	FAT4 LGI1	2.04e-03	14	143	2	EFO_0004670, EFO_0006794
Disease	idiopathic osteonecrosis of the femoral head	GPBP1 ABCG1 SORCS2	2.07e-03	52	143	3	EFO_1001930
Disease	Malignant neoplasm of breast	VWF FAM210A CD109 SPAG6 PPP1R3A BRCA2 CLIC1 ANKEF1 KCNJ15 ATM DNASE1L3 GAB1 SORL1	2.24e-03	1074	143	13	C0006142
Disease	glycerol-3-phosphate measurement	CFAP43 ALPL	2.35e-03	15	143	2	EFO_0010488
Disease	filaggrin gene expression measurement	TRPS1 FRMD4A	2.68e-03	16	143	2	EFO_0020899
Disease	uterine fibroid	GPBP1 RTEL1 CD109 CDCA2 ATM	2.91e-03	199	143	5	EFO_0000731
Disease	factor VIII measurement, Ischemic stroke	VWF FCHO2	3.78e-03	19	143	2	EFO_0004630, HP_0002140
Disease	Adenocarcinoma of prostate	BRCA2 ATM	4.18e-03	20	143	2	C0007112
Disease	Liver Cirrhosis, Experimental	SYNRG VWF RGS5 NBEA JAK2 ABCG1 CLIC1 CLEC4A PLSCR1 KNG1	4.57e-03	774	143	10	C0023893
Disease	BREAST CANCER	BRCA2 ATM	4.61e-03	21	143	2	114480

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSSLTQYQRFFKGDK	ZNF354C	536	Q86Y25
VFKFSSQGQIFSKFN	CYP4Z2P	236	Q8N1L4
NSQSGNALTAYALFK	FAM210A	181	Q96ND0
GKFSNQKDIANYALS	CFAP43	1576	Q8NDM7
FSSLTKQFVGYLDKA	C1orf141	321	Q5JVX7
ENAAKYTSLGKVQFF	C2orf78	891	A6NCI8
KTDKNFFAYATGRGL	CCDC7	1146	Q96M83
NEAKKVLSNSGFLFF	ABCG1	446	P45844
LFNFFGQTSLFKTKN	ADGRG4	2626	Q8IZF6
KNSYGKVTAEFNLTA	ALPK2	1861	Q86TB3
FSSDFSIQKKGFNAS	ADGRG6	131	Q86SQ4
QLLSFGKAKSGYFLS	ADGRG6	211	Q86SQ4
LAKSASNYSQLGTFA	FCHO2	56	Q0JRZ9
NAPKFLKDFYQATIS	FAT4	1206	Q6V0I7
SNDNAPQFLKSKYFT	FAT4	2976	Q6V0I7
FYKFNTSLAGDLTNL	CACHD1	901	Q5VU97
NINEFFKGTRYLNKS	ANKEF1	391	Q9NU02
FFSKYVDNPQKTAAT	ACSM4	431	P0C7M7
NFFSSLFSKYSKNEG	CLCN4	236	P51793
VSGTRKNKFSEAAYN	ARMC3	531	Q5W041
KAFTQDKFSKNSLYF	ARMCX4	2241	Q5H9R4
NTFNKDSFSAFKSAV	ATG2B	996	Q96BY7
QLKAFALKSADFSSY	ASXL3	2111	Q9C0F0
LKGYVNNSLSFFDLS	ANO3	861	Q9BYT9
AQGISANKFVDSTFY	NUP93	676	Q8N1F7
FANKSGQSALYDALF	RANBP2	376	P49792
EYNLSGTKKNFSSLK	JAK2	461	O60674
KIAASEKFTNFNLFY	AOAH	486	P28039
IDNKALYNIFSAFGN	PABPC1L2A	101	Q5JQF8
SNFRAAKKLFGSTFA	PARP8	681	Q8N3A8
FAQTFSKKQNFTFLG	MDN1	736	Q9NU22
GFQAQSFIATLKYLD	FRAS1	3311	Q86XX4
SNAKKYQLTNAFGSF	LONP2	706	Q86WA8
FGLTVYTLQSKKDFS	TMBIM4	136	Q9HC24
SSKGADKSSNFLYLQ	HTATIP2	131	Q9BUP3
VGNFNAFKSTAKNFS	GPBP1	246	Q86WP2
ASTFPQFIKAYKTGN	SLC66A1	51	Q6ZP29
GLTFNKKEFENSYIF	GAB1	71	Q13480
TDFLLNKSIYKQFAA	HECTD2	621	Q5U5R9
DSYGSKSNILRFFAK	EFHC2	426	Q5JST6
SSLKASYEAFKNNDF	ING3	246	Q9NXR8
YFKDGKAINVFVSAN	PDCD10	181	Q9BUL8
TGFETNNKYEIKNSF	PLSCR1	121	O15162
ASKDQGKFLTLFYTV	OR2W1	266	Q9Y3N9
FSSFLKEKLNDTYVN	NEMP1	116	O14524
AAVKSTANKYQVFFF	HDGF	36	P51858
SLSKNGKYVADFSQF	KCNJ15	316	Q99712
GNLLTSKFFSYKDFD	DPY19L1	371	Q2PZI1
KKFLQVGDAFAVSYA	EVC2	231	Q86UK5
FKEDYVQKNTFGSTS	EXPH5	306	Q8NEV8
SSYKAGEFFLKNLVA	LIAS	351	O43766
SKQDQGKFISLFYSL	OR2C1	266	O95371
DNKALYDTFSTFGNI	PABPC1L	111	Q4VXU2
AIKNAKSNNESSFYA	PRPF39	481	Q86UA1
GLGDSSYAKFNFVAK	NDOR1	96	Q9UHB4
AQGNESLFSKYTNSK	PPP1R3A	1061	Q16821
KFPFVALSKTYNTNA	ALPL	91	P05186
SGQKKDTEIFYQFTS	PREP	386	P48147
TFANKSGQSALYDAL	RGPD3	376	A6NKT7
NAYGFKISSLNKIAD	DAAM1	831	Q9Y4D1
QFKTSNSYTAGGLFK	FRMD4A	866	Q9P2Q2
QTDGLNSKFLDFFSK	ATM	201	Q13315
RKDYTAAGFSSFQKI	ADAMTS9	1816	Q9P2N4
TKTFKINGSANFSFN	CD109	281	Q6YHK3
QLKNRGKYEIAFSFS	HYDIN	3071	Q4G0P3
VLSGSKKDYKLNFFS	HYDIN	4786	Q4G0P3
YQFDVSLANKFAGSN	BNIP5	601	P0C671
QSFAKFSKFGDDLYS	DNASE2	226	O00115
SNSVFDFQKAYKLTE	DNASE1L3	251	Q13609
NSKSINLKDFFGAYT	CYP3A43	166	Q9HB55
KFSEKFQRYSAFSLG	EFNA3	121	P52797
NKYLTAEAFGFKVNA	FSCN1	21	Q16658
SFSKVISNVKDANAY	BRCA2	1786	P51587
KNGFSKAYFTAANGV	ELOVL2	276	Q9NXB9
TDYKKGFSFAFEQLL	CACNA2D1	331	P54289
SATLNAEKFSEYFGN	DHX36	366	Q9H2U1
KSSASFNVIEFPYKN	ITGAV	951	P06756
FLNGTNAKAFELSYL	FHOD3	1096	Q2V2M9
TAALTLYTKKQFFQG	HAUS3	211	Q68CZ6
FKSANSLSGKLTNLY	DNAH14	1281	Q0VDD8
STLANTKATSQFKGY	CDCA2	981	Q69YH5
SVNATYSDFKSNFAK	CDC20B	46	Q86Y33
YSDFKSNFAKRLSAE	CDC20B	51	Q86Y33
TSDFKAKSSIQFYNK	KLB	946	Q86Z14
ITKLNAENNATFYFK	KNG1	286	P01042
NNAFSGVATYTDKLF	CRTAC1	136	Q9NQ79
SAQDGRNSTFQTYKK	C16orf95	46	Q9H693
LGETFFSKSQIYKGN	CCDC168	2551	Q8NDH2
FGVKYNASSFAKFTL	CDH17	541	Q12864
EKSLKFYGSIQEFSS	SLC15A5	556	A6NIM6
TNGLYNQFIKSLDSF	RYR1	406	P21817
YGFIQNTSKFNFPKS	GSTCD	541	Q8NEC7
YSTAQKAVGKDNFTL	CRMP1	336	Q14194
AEDKSQLFNAKNSSY	FAM171B	421	Q6P995
FSKYTAGASLFQNAE	HOXA7	11	P31268
FLLTDSEKGNSYKFQ	RALGPS2	536	Q86X27
NSIGSFQAKRYVFKS	KIF23	141	Q02241
LDNKLSKSVSSGYNF	P2RX5	281	Q93086
NFATFTQALQDYKGS	RTEL1	911	Q9NZ71
SFNLKALSGSSGYKF	GTF2E2	61	P29084
AAFQASKRNGKAYAS	TSGA10IP	346	Q3SY00
TFANKSGQSALYDAL	RGPD4	376	Q7Z3J3
TAYLGNTTDNFFKIS	SORL1	2071	Q92673
SLAEQNRFYKKAAAF	SPAG6	91	O75602
PLAGNKDNKFSFSFS	PHF2	626	O75151
KAFNSETDSFKLAYG	SYNRG	1271	Q9UMZ2
NNYGLASFKSFLKSE	RGS5	71	O15539
KAAQSFSNALYLQDG	ODAD4	31	Q96NG3
DGKLASSIAFTYNAK	NBEA	436	Q8NFP9
DDYIFFKATSANQTK	SORCS2	351	Q96PQ0
NEKKSRGFFNYQASI	SLC12A1	351	Q13621
DFGLSNLYQKDKFLQ	NUAK1	196	O60285
NLYQKDKFLQTFCGS	NUAK1	201	O60285
LYAFLSDNFKKSFQN	SSTR2	311	P30874
SFLYSAAKFDTQGKA	STC1	76	P52823
AGLDIFAKFSAYIKN	CLIC1	106	O00299
FAKFSAYIKNSNPAL	CLIC1	111	O00299
TYAEVRFKNEFKSSG	CLEC4A	6	Q9UMR7
KGSFRNASFFKQLSL	C15orf62	6	A8K5M9
SKQFSNDVYTSSVGK	C11orf53	26	Q8IXP5
VFKFSSQGQIFSKFN	CYP4Z1	236	Q86W10
FLFQLSFSTLGKDYS	GTF2H4	236	Q92759
STFLNKFLEKQYGTS	SLCO2A1	346	Q92959
TGQIFNQSYSKFDTK	GH2	161	P01242
KSAVLSEKAGFNYES	TRPS1	76	Q9UHF7
AHFGSEKSNLYKFTA	ZNF451	821	Q9Y4E5
KAIVASKASQFTGYA	USP19	571	O94966
EFKNAVSKYGSQFQG	USP43	166	Q70EL4
STVTSKGFAQYELFK	ZWILCH	196	Q9H900
KGFAQYELFKSSALD	ZWILCH	201	Q9H900
KTKYNFNNRGSLTFE	XPNPEP1	546	Q9NQW7
GPFQSSKNSYIKLSF	VPS36	96	Q86VN1
FKLTGSCSYVLFQNK	VWF	1966	P04275
FSFSNTASLKYGIVQ	MINDY4	436	Q4G0A6
YIIKKDFFGLDTNSA	NUFIP1	476	Q9UHK0
FGFGSSSKYDKIADQ	PHIP	541	Q8WWQ0
ISKNFGADTTKVFYI	PITHD1	156	Q9GZP4
DFRKKLNAGYSNTAT	WDHD1	836	O75717
KFYLQDTKSSNGTFI	SLMAP	66	Q14BN4
SDCGKFFTFNSNLLK	ZNF256	606	Q9Y2P7
KQYDSFTFTASKNGT	TMED7	91	Q9Y3B3
KKNSLYSTDFIVFND	ZNF292	636	O60281
KGYVNSSSQIKASFS	WDR44	781	Q5JSH3
ISFVTKNFFSKANGN	VIT	376	Q6UXI7
QYVSAFSKLAKDSNT	STOML2	281	Q9UJZ1
ISDDKSEYLFKFNSS	TFDP3	271	Q5H9I0
FKVNDKSVGGSFYLQ	PAM16	81	Q9Y3D7
KSASVQGFFLNHYLS	PTGR3	296	Q8N4Q0
PKVFSNFYSKAGNIS	VIPR2	76	P41587
PYKVQSNGDFSKNSF	ZBTB39	246	O15060
TYVFKDSSQKDLLNF	UEVLD	41	Q8IX04
AAYSSLDTSKFKNQG	TEX33	31	O43247
KDGRTNTQEKSFAYS	ZNF782	176	Q6ZMW2
ASSKESAKLYGSFNF	TMEM74	266	Q96NL1
VALSSYNKFKNNCFS	SLC6A14	331	Q9UN76
FYTQKNKSASVFLGT	TTLL5	806	Q6EMB2
SQYFKKLFTSGAVVD	ZBTB7A	56	O95365
NKRNFLFASSFKGNT	LGI1	531	O95970
LFASSFKGNTQIYKH	LGI1	536	O95970
FAKDQASRKSYISGN	NDEL1	276	Q9GZM8